Table 1.
Characteristics of the participants (n = 20) recruited into the NutriCare pilot trial.
| n (%) or Mean (SD) | |
|---|---|
| Age, years, mean (SD) | 59.5 (9.9) |
| BMI, mean (SD) | 30.2 (6.4) |
| BMI classification, n (%) | |
| Underweight (<18.5 kg/m2) | 0 (0) |
| Healthy weight (18.5–24.99 kg/m2) | 6 (32) |
| Overweight (25–29.99 kg/m2) | 3 (15) |
| Obese (≥30 kg/m2) | 10 (53) |
| Weight gain, since diagnosis, n (%) | |
| Yes | 6 (30) |
| No | 14 (70) |
| Weight loss, since diagnosis, n (%) | |
| Yes | 3 (15) |
| No | 17 (85) |
| Diagnosis, years since, n (%) | |
| <5 years | 9 (45) |
| 5–10 years | 7 (35) |
| 10–15 years | 1 (5) |
| 15+ years | 3 (15) |
| Breast cancer stage, n (%) | |
| 1A | 5 (25) |
| 1B | 0 (0) |
| 2A | 7 (35) |
| 2B | 3 (15) |
| 3A | 2 (10) |
| 3B | 1 (5) |
| 3C | 2 (10) |
| Hormonal Receptor Status, n (%) | |
| ER + PR + HER2- | 10 (50) |
| ER-PR-HER2- | 1 (5) |
| ER + PR + HER2 1 + | 3 (15) |
| ER + PR + HER2 2 + | 1 (5) |
| ER + PR + HER2 3 + | 2 (10) |
| ER + PR + HER- | 1 (5) |
| ER-PR-HER- | 1 (5) |
| Previous Surgery, n (%) | |
| Yes | 16 (80) |
| No | 4 (20) |
| Previous Radiation, n (%) | |
| Yes | 15 (75) |
| No | 5 (25) |
| Years since radiation completion, mean(SD) | 4.3 (4.1) |
| Previous Chemotherapy, n (%) | |
| Yes | 15 (75) |
| No | 5(25) |
| Years since chemotherapy completion, mean(SD) | 6.5 (6.4) |
| Hormonal Therapy, n (%) | |
| Current | 15 (75) |
| Previous | 4 (20) |
| Never | 1 (5) |
| Race/ethnicity, n (%) | |
| White Caucasian | 18 (90) |
| Black/African American | 1 (5) |
| Other | 1 (5) |
| Education, n (%) | |
| High school | 4 (20) |
| Associates degree | 3 (15) |
| Some college | 3 (15) |
| College | 8 (40) |
| Graduate | 2 (10) |